U.S. retail sales for February, data Fed officials will see before kicking off their two-day policy meeting on Tuesday, were ...
making it one of the most expensive therapies in the U.S. Mizuho said the selling of the stock was likely an overreaction, noting that this is the first case of acute liver failure among patients ...
During Donald Trump’s first term as US president, he regularly referred to rising stock markets as evidence of the success of ...
When President Trump entered his first term, stocks were steadily marching upward. This time, the trajectory has inverted.
The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.